Status and phase
Conditions
Treatments
About
An open-label follow-up trial assessing the long term safety of levetiracetam as per adverse events reporting.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
66 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal